Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed Nov 13, 2018 · 10-Q · 44 days after period end · 0001564590-18-029125
| Metric | Q3 2018 | Q3 2017 |
|---|---|---|
| Revenue | $198.00K | — |
| Net Income | -$6.60M | -$5.54M |
| EPS Diluted | -$0.93 | -$5.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 13, 2018 · 44 d after period end
